Company: ABBV
Filing Date: 2025-02-18
Form Type: 424B5
Source: 0001104659-25-014554
Chunk: 73

Company: AbbVie Inc.
Filing Date: 2025-02-18
Form: 424B5
Chunk 73
---
 while the offering is in progress.

Underwriters may also impose a penalty bid in any offering of debt securities offered under this prospectus and any prospectus supplement through a syndicate of underwriters. This occurs when a particular underwriter repays to the underwriters a portion of the underwriting discount received by it

<div align='center'>10</div>

TABLE OF CONTENTS

because the other underwriters have repurchased debt securities sold by or for the account of such underwriter in stabilizing or short covering transactions.

These activities by underwriters may stabilize, maintain or otherwise affect the market price of the debt securities offered under this prospectus and any prospectus supplement. As a result, the price of such debt securities may be higher than the price that otherwise might exist in the open market. If these activities are commenced, they may be discontinued by underwriters at any time. These transactions may be effected in the over-the-counter market or otherwise.

<div align='center'>11</div>

TABLE OF CONTENTS

### LEGAL MATTERS
Unless otherwise indicated in the applicable prospectus supplement, legal matters in connection with the debt securities offered under this prospectus will be passed upon for us by Kirkland & Ellis LLP, New York, New York, and for any underwriters or agents by counsel named in the applicable prospectus supplement.

### EXPERTS
The consolidated financial statements of AbbVie Inc. appearing in our Annual Report on Form 10-K for the year ended December 31, 2024, and the effectiveness of the Company’s internal control over financial reporting as of December 31, 2024, have been audited by Ernst & Young LLP, independent registered public accounting firm, as set forth in their reports thereon, included therein, and incorporated herein by reference. Such consolidated financial statements are incorporated herein by reference in reliance upon such reports given on the authority of such firm as experts in accounting and auditing.

<div align='center'>12</div>

TABLE OF CONTENTS

<div align='center'>**$ % SENIOR NOTES DUE 20 
 $ % SENIOR NOTES DUE 20 
 $ % SENIOR NOTES DUE 20 
 $ % SENIOR NOTES DUE 20**</div>

#### Joint Book-Running Managers

#### BofA Securities

#### J.P. Morgan

#### Morgan Stanley

#### Barclays

#### Mizuho

#### , 2025